To amend the Federal Food, Drug, and Cosmetic Act to provide for expedited approval of priority nonprescription drugs, and for other purposes.
119-HR-9774119th CongressIntroduced Jul 20, 2026Health
Market Probability
No market
Status
Introduced
Committee
Floor Vote
Other Chamber
Signed
Referred to the House Committee on Energy and Commerce.
Sponsor
Rep. Latta, Robert E. [R-OH-5](R-OH-5)1 cosponsor
Actions (3)
Referred to the House Committee on Energy and Commerce.
Jul 20, 2026House floor actions
Introduced in House
Jul 20, 2026Library of Congress
Introduced in House
Jul 20, 2026Library of Congress